Follow
Kehmia Titanji
Kehmia Titanji
Emory University School of Medicine
Verified email at emory.edu
Title
Cited by
Cited by
Year
Enhancing SIV-specific immunity in vivo by PD-1 blockade
V Velu, K Titanji, B Zhu, S Husain, A Pladevega, L Lai, TH Vanderford, ...
Nature 458 (7235), 206-210, 2009
9562009
Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection
A De Milito, A Nilsson, K Titanji, R Thorstensson, E Reizenstein, M Narita, ...
Blood 103 (6), 2180-2186, 2004
3962004
Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection
A De Milito, A Nilsson, K Titanji, R Thorstensson, E Reizenstein, M Narita, ...
Blood 103 (6), 2180-2186, 2004
3962004
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
K Titanji, A De Milito, A Cagigi, R Thorstensson, S Grützmeier, A Atlas, ...
Blood 108 (5), 1580-1587, 2006
3482006
Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions
K Titanji, F Chiodi, R Bellocco, D Schepis, L Osorio, C Tassandin, ...
Aids 19 (17), 1947-1955, 2005
2042005
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
RD Shetty, V Velu, K Titanji, SE Bosinger, GJ Freeman, G Silvestri, ...
The Journal of clinical investigation 122 (5), 1712-1716, 2012
1892012
Midgut bacterial dynamics in Aedes aegypti
O Terenius, JM Lindh, K Eriksson-Gonzales, L Bussière, AT Laugen, ...
FEMS microbiology ecology 80 (3), 556-565, 2012
1452012
Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques
K Titanji, V Velu, L Chennareddi, M Vijay-Kumar, AT Gewirtz, GJ Freeman, ...
The Journal of clinical investigation 120 (11), 3878-3890, 2010
1392010
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection
K Titanji, A Vunnava, AN Sheth, C Delille, JL Lennox, SE Sanford, ...
PLoS pathogens 10 (11), e1004497, 2014
1192014
Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection
I Ofotokun, K Titanji, A Vunnava, S Roser-Page, T Vikulina, F Villinger, ...
Aids 30 (3), 405-414, 2016
1092016
Astrocyte activation and apoptosis: their roles in the neuropathology of HIV infection
F Sabri, K Titanji, A De Milito, F Chiodi
Brain pathology 13 (1), 84-94, 2003
942003
Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss
I Ofotokun, K Titanji, T Vikulina, S Roser-Page, M Yamaguchi, ...
Nature communications 6 (1), 8282, 2015
762015
Methods for the treatment of infections and tumors
R Ahmed, R Amara, V Velu, K Titanji, G Freeman
US Patent 9,598,491, 2017
522017
A single-dose zoledronic acid infusion prevents antiretroviral therapy–induced bone loss in treatment-naive HIV-infected patients: A phase IIb trial
I Ofotokun, K Titanji, CD Lahiri, A Vunnava, A Foster, SE Sanford, ...
Clinical Infectious Diseases 63 (5), 663-671, 2016
492016
Beyond antibodies: B cells and the OPG/RANK-RANKL pathway in health, non-HIV disease and HIV-induced bone loss
K Titanji
Frontiers in Immunology 8, 316194, 2017
392017
Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection
K Titanji, A Nilsson, C Mörch, A Samuelsson, A Sönnerborg, S Grutzmeier, ...
Clinical & Experimental Immunology 132 (2), 297-303, 2003
382003
Soluble CD27 induces IgG production through activation of antigen‐primed B cells
LVP Dang, A Nilsson, H Ingelman‐Sundberg, A Cagigi, LBS Gelinck, ...
Journal of internal medicine 271 (3), 282-293, 2012
372012
Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus‐1 infection
K Titanji, S Sammicheli, A De Milito, P Mantegani, C Fortis, L Berg, ...
Immunology 123 (2), 164-170, 2008
352008
T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts
K Titanji, A Vunnava, A Foster, AN Sheth, JL Lennox, A Knezevic, ...
Aids 32 (7), 885-894, 2018
292018
Surrogate markers as a guide to evaluate response to antiretroviral therapy
A Milito, K Titanji, M Zazzi
Current medicinal chemistry 10 (5), 349-365, 2003
252003
The system can't perform the operation now. Try again later.
Articles 1–20